Document Detail

Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers: a prospective randomized study.
MedLine Citation:
PMID:  12882865     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To study the effect of systemic hyperbaric oxygenation (HBO) therapy on the healing course of nonischemic chronic diabetic foot ulcers. RESEARCH DESIGN AND METHODS: From 1999 to 2000, 28 patients (average age 60.2 +/- 9.7 years, diabetes duration 18.2 +/- 6.6 years), of whom 87% had type 2 diabetes, demonstrating chronic Wagner grades I-III foot ulcers without clinical symptoms of arteriopathy, were studied. They were randomized to undergo HBO because their ulcers did not improve over 3 months of full standard treatment. All the patients demonstrated signs of neuropathy. HBO was applied twice a day, 5 days a week for 2 weeks; each session lasted 90 min at 2.5 ATA (absolute temperature air). The main parameter studied was the size of the foot ulcer measured on tracing graphs with a computer. It was evaluated before HBO and at day 15 and 30 after the baseline. RESULTS: HBO was well tolerated in all but one patient (barotraumatic otitis). The transcutaneous oxygen pressure (TcPO(2)) measured on the dorsum of the feet of the patients was 45.6 +/- 18.1 mmHg (room air). During HBO, the TcPO(2) measured around the ulcer increased significantly from 21.9 +/- 12.1 to 454.2 +/- 128.1 mmHg (P < 0.001). At day 15 (i.e., after completion of HBO), the size of ulcers decreased significantly in the HBO group (41.8 +/- 25.5 vs. 21.7 +/- 16.9% in the control group [P = 0.037]). Such a difference could no longer be observed at day 30 (48.1 +/- 30.3 vs. 41.7 +/- 27.3%). Four weeks later, complete healing was observed in two patients having undergone HBO and none in the control group. CONCLUSIONS: In addition to standard multidisciplinary management, HBO doubles the mean healing rate of nonischemic chronic foot ulcers in selected diabetic patients. The time dependence of the effect of HBO warrants further investigations.
Laurence Kessler; Pascal Bilbault; Francoise Ortéga; Claire Grasso; Raphael Passemard; Dominique Stephan; Michel Pinget; Francis Schneider
Related Documents :
25282395 - Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic s...
19547695 - [in process citation].
24700895 - Suction catheter guided insertion of proseal laryngeal mask airway: experience by untra...
19863325 - Uvulopalatopharyngoplasty in 158 osas patients failing non-surgical treatment.
22219405 - Adverse effects of fibrin sealants in thoracic surgery: the safety of a new fibrin seal...
23549765 - Systematic pancreatic stenting after endoscopic snare papillectomy may reduce the risk ...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Diabetes care     Volume:  26     ISSN:  0149-5992     ISO Abbreviation:  Diabetes Care     Publication Date:  2003 Aug 
Date Detail:
Created Date:  2003-07-28     Completed Date:  2003-11-04     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7805975     Medline TA:  Diabetes Care     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2378-82     Citation Subset:  IM    
Department of Endocrinology and Diabetology, University Hospital, Strasbourg, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Chronic Disease
Diabetic Foot / pathology,  therapy*
Hyperbaric Oxygenation* / adverse effects
Middle Aged
Prospective Studies
Treatment Outcome
Wound Healing*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or ...
Next Document:  Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with ...